Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$6.28 0.12 (1.95%)
2/9/2010 4:04 PM

CryoLife, Inc. (CRY)

CAPS Rating:
*****

The Company develops and commercializes biomaterials, implantable medical devices, and preserves and distributes human tissues for cardiovascular and vascular transplant applications.

X

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating CRY

Add Stock to Watchlist

What the Community Thinks

Total Members

294 Outperforms
10 Underperforms
 

All-Stars

82 Outperforms
3 Underperforms
 

Wall Street

3 Outperforms
0 Underperforms
 

Members bullish on CRY are also bullish on:

Members bearish on CRY are also bearish on:

Ticker Tags

Georgia (19), Healthcare (711), Healthcare Equipment and Supplies (176), It's a Verb! (39), Defensive (1457), Specialized Health Services (6), Micro Cap (4701)
Suggest a tag

CryoLife, Inc. At A Glance

Current Price: $6.28
Last Trade Time: 2/9/2010 4:04 PM
Open: $6.21
Previous Close: $6.16
Daily Range: $6.14 - $6.38
52-Week Range: $3.93 - $8.87
Volume: 71,933
Market Cap: $178.75M
P/E Ratio: 5.98
Compare Our Special Broker Offers!

Stock Trends

CRY VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

5

CryoLife, Inc. (CRY)

Avatar TSIF (98.89) Submitted: 9/14/09 4:49 PM

Cryolife is an interesting pick for me. Most pharmaceutical/bio type companies with products in development are playing roulette with the quirky FDA, buring through cash, and hoping for either a win, a buyout, or both. CryoLife differs in that they have been around for decades, cash positive. A year...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 55 :   1 2 3 4 5 Next » Jump to page:

Show Pitch Replies

Recs

0

 (CRY)

Avatar GreatStocks3728 (< 20) Submitted: 2/02/10 4:18 PM : Outperform Start Price: $6.32 CRY Score: 1.79

Goog growth and earnings.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CRY)

Avatar Contralogic (58.48) Submitted: 1/31/10 5:53 PM : Outperform Start Price: $6.39 CRY Score: -0.86

Good potential with Cryolife.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CRY)

Avatar nibs61 (69.52) Submitted: 1/29/10 11:58 AM : Outperform Start Price: $6.48 CRY Score: -1.90

I was turned on to this by another fool. When I went to look I saw a solid stock that is recession proof but what really made me look hard is their R&D projects. If they can get thier BioGlue to work for herniated discs this could be off and running. Also they have goverment funding to research BioFoam to help stop wounded soldiers in the field. Speculative on the upside and solid on the earnings side so as to not lose if the new projects don't come to fruition. Worth the risk and am buying some in my personal account.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CRY)

Avatar jc09058 (91.77) Submitted: 1/29/10 10:13 AM : Outperform Start Price: $6.48 CRY Score: -1.09

Bio companies have become a recent interest because of the baby boomers aging and growing need for medical services during the next 20 years. Overall, the products offered by this company seem to be just the thing needed for now and the future. While I do have some concern of future legislation that can effect this company's profit line, I feel comfortable with it's future growth. Price had been beaten down and sales do seem off and on, but I think future developments and FDA approvals will be more forthcoming. Long haul and hold will be the key factor for this stock.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CRY)

Avatar 3domfighter (< 20) Submitted: 1/12/10 9:12 PM : Outperform Start Price: $6.58 CRY Score: 1.35

CryoLife's primary product is involved in the treatment of heart disease, the number one killer of men and women. In fact, one of every four deaths is due to the disease, so I like their prospects in that regard. They exhibit solid growth in revenue and net income while trading a very modest P/E ratio of about 6.5

Report this Post Replies: 2 | Reply | Permalink

Results 1 - 5 of 55 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 3 of 3  

picks per page. CHANGE

Top
Pick		Member NameMember RatingStart
Date		CallTime FrameStart
Price		Stock
Gain		S&P
Gain		ScorePitch
TrackRothCapital 80.39 03/31/08 Outperform NS $9.73-35.46%-15.31%-20.15
TrackJesupLamont < 20 03/18/08 Outperform NS $8.64-27.31%-14.45%-12.86
TrackPiperJaff 85.79 05/02/07 Outperform NS $10.20-38.43%-23.87%-14.56

Results 1 - 3 of 3  

X

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD02 187ms